Showing results (61-70 of 88) with videos related to
Sort By:
Pageof 9
Psychiatric Services (Washington, D.C.)|December 3, 2020
Medicaid Expansion and Availability of Opioid Medications in the Specialty Substance Use Disorder Treatment SystemAmanda J Abraham, Courtney R Yarbrough, Samantha J Harris, et al.Health Affairs (Project Hope)|July 1, 2024
Most States Allow Medicaid Managed Care Plans Discretion To Restrict Substance Use Disorder Treatment BenefitsLauren A Peterson, Christina M Andrews, Amanda J Abraham, et al.JAMA Network Open|September 5, 2024
Cannabis Laws and Utilization of Medications for the Treatment of Mental Health DisordersAshley C Bradford, Felipe Lozano-Rojas, Hailemichael Bekele Shone, et al.Journal of Substance Abuse Treatment|August 12, 2011
Timing of buprenorphine adoption by privately funded substance abuse treatment programs: the role of institutional and resource-based interorganizational linkagesSarah A Savage, Amanda J Abraham, Hannah K Knudsen, et al.Addictive Behaviors|March 6, 2014
Impact of research network participation on the adoption of buprenorphine for substance abuse treatmentTraci R Rieckmann, Amanda J Abraham, Anne E Kovas, et al.American Journal of Public Health|March 21, 2024
State Medicaid Initiatives Targeting Substance Use Disorder in Criminal Legal Settings, 2021Cashell D Lewis, Christina Andrews, Amanda J Abraham, et al.JAMA Health Forum|October 17, 2025
Cannabis Laws and Opioid Use Among Commercially Insured Patients With Cancer DiagnosesFelipe Lozano-Rojas, Victoria Bethel, Sumedha Gupta, et al.Health Affairs (Project Hope)|January 8, 2024
Medicaid Managed Care Prior Authorization For Buprenorphine Tied To State Partisanship And Health Plan Profit Status, 2018Christina M Andrews, Melissa A Westlake, Amanda J Abraham, et al.Journal of Substance Use and Addiction Treatment|May 8, 2023
Allocation of federal funding to address the opioid overdose crisis in the criminal legal systemSamantha J Harris, Amanda J Abraham, Felipe Lozano-Rojas, et al.American Journal of Public Health|January 25, 2019
Impact of Medicaid Restrictions on Availability of Buprenorphine in Addiction Treatment ProgramsChristina M Andrews, Amanda J Abraham, Colleen M Grogan, et al.Pageof 9